Dr. Ramaswami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ccr 10 Center Drive Room 6n110
Bethesda, MD 20892Phone+1 301-451-9018
Education & Training
- Imperial College London School of MedicineClass of 2007
Certifications & Licensure
- ME State Medical License 2020 - 2026
Clinical Trials
- NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma Start of enrollment: 2020 Jul 13
- NT-I7 for Kaposi Sarcoma in Patients With or Without HIV Start of enrollment: 2022 May 23
- Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma Start of enrollment: 2016 Jan 13
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 55 citationsPembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.Thomas S Uldrick, Scott V Adams, Remi Fromentin, Michael Roche, Steven P Fling
Science Translational Medicine. 2022-01-26 - 46 citationsIntensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.Fieke E. M. Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos, Baljeet Kaur, Neil J. Sebire
British Journal of Cancer. 2019-02-22 - 76 citationsPrecision Medicine from a Public Health Perspective.Ramya Ramaswami, Ronald Bayer, Sandro Galea
Annual Review of Public Health. 2018-04-02
Journal Articles
- Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNARamya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences
Press Mentions
- HIV-Associated Cancers and Lymphoproliferative Disorders Caused by Kaposi Sarcoma Herpesvirus and Epstein-Barr VirusJune 25th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: